Q4 2024 Management View CEO Tony Sarsam highlighted SpartanNash's third consecutive year of record adjusted EBITDA, reaching $258 million, driven by improvements in wholesale margins, efficiencies in ...

TD Cowen increased its price target on Gilead Sciences (NASDAQ:GILD) shares to $100 from the previous $95, while maintaining a Buy rating on the stock. The biotech giant, currently trading near its 52 ...